Nosocomial infection: A risk factor for a complicated course in children with respiratory syncytial virus infection - Results from a prospective multicenter German surveillance study

International Journal of Hygiene and Environmental Health

Volumn 211, Issue 3-4, 2008, Pages 241-250

  Simon, Arne ^a   Müller, Andreas ^a   Khurana, Karun ^a   Engelhart, Steffen ^a   Exner, Martin ^a   Schildgen, Oliver ^a   Eis Hübinger, Anna M ^a   Kamin, Wolfgang ^b   Schaible, Thomas ^c   Wadas, Karoline ^d   Ammann, Roland A ^e   Wilkesmann, Anja ^a  

^a UNIVERSITY OF BONN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF MANNHEIM   (Germany)

^d ST JOHANNES HOSPITAL   (Germany)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Chronic lung disease; Illness severity; Nosocomial infection; Premature infants; Respiratory syncytial virus

Indexed keywords

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 45349096928     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2007.07.020     Document Type: Article

References (43)

1. Abadesso C., Almeida H.I., Virella D., Carreiro M.H., and Machado M.C. Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit. J. Hosp. Infect. 58 (2004) 38-41
2. Abels S., Nadal D., Stroehle A., and Bossart W. Reliable detection of respiratory syncytial virus infection in children for adequate hospital infection control management. J. Clin. Microbiol. 39 (2001) 3135-3139
3. Altman C.A., Englund J.A., Demmler G., Drescher K.L., Alexander M.A., Watrin C., and Feltes T.F. Respiratory syncytial virus in patients with congenital heart disease: a contemporary look at epidemiology and success of preoperative screening. Pediatr. Cardiol. 21 (2000) 433-438
4. Arnold S.R., Wang E.E., Law B.J., Boucher F.D., Stephens D., Robinson J.L., Dobson S., Langley J.M., McDonald J., MacDonald N.E., et al. Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada. Pediatr. Infect. Dis. J. 18 (1999) 866-869
5. Black C.P. Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir. Care 48 (2003) 209-231 (discussion 231-3)
6. Borek A.P., Clemens S.H., Gaskins V.K., Aird D.Z., and Valsamakis A. Respiratory syncytial virus detection by Remel Xpect, Binax Now RSV, direct immunofluorescent staining, and tissue culture. J. Clin. Microbiol. 44 (2006) 1105-1107
7. Buckingham S.C., Quasney M.W., Bush A.J., and DeVincenzo J.P. Respiratory syncytial virus infections in the pediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes. Pediatr. Crit. Care Med. 2 (2001) 318-323
8. Cox R.A., Rao P., and Brandon-Cox C. The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit. J. Hosp. Infect. 48 (2001) 186-192
9. Donnelly L.F. Practical issues concerning imaging of pulmonary infection in children. J. Thorac. Imaging 16 (2001) 238-250
10. Ehlken B., Ihorst G., Lippert B., Rohwedder A., Petersen G., Schumacher M., and Forster J. Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. Eur. J. Pediatr. 164 (2005) 607-615
11. Feltes T.F., Cabalka A.K., Meissner H.C., Piazza F.M., Carlin D.A., Top Jr. F.H., Connor E.M., and Sondheimer H.M. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J. Pediatr. 143 (2003) 532-540
12. Fitzgerald D.A., and Kilham H.A. Bronchiolitis: assessment and evidence-based management. Med. J. Aust. 180 (2004) 399-404
13. Forster J., and Schumacher R.F. The clinical picture presented by premature neonates infected with the respiratory syncytial virus. Eur. J. Pediatr. 154 (1995) 901-905
14. Forster J., Ihorst G., Rieger C.H., Stephan V., Frank H.D., Gurth H., Berner R., Rohwedder A., Werchau H., Schumacher M., et al. Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study). Eur. J. Pediatr. 163 (2004) 709-716
15. Goldstein B., Giroir B., and Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr. Crit. Care Med. 6 (2005) 2-8
16. Groothuis J.R., Gutierrez K.M., and Lauer B.A. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 82 (1988) 199-203
17. Hall C.B. Nosocomial respiratory syncytial virus infections: the "Cold War" has not ended. Clin. Infect. Dis. 31 (2000) 590-596
18. Heerens A.T., Marshall D.D., and Bose C.L. Nosocomial respiratory syncytial virus: a threat in the modern neonatal intensive care unit. J. Perinatol. 22 (2002) 306-307
19. Howard T.S., Hoffman L.H., Stang P.E., and Simoes E.A. Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality. J. Pediatr. 137 (2000) 227-232
20. Jennings L.C., Anderson T.P., Werno A.M., Beynon K.A., and Murdoch D.R. Viral etiology of acute respiratory tract infections in children presenting to hospital: role of polymerase chain reaction and demonstration of multiple infections. Pediatr. Infect. Dis. J. 23 (2004) 1003-1007
21. Johnston S.L., and Siegel C.S. Evaluation of direct immunofluorescence, enzyme immunoassay, centrifugation culture, and conventional culture for the detection of respiratory syncytial virus. J. Clin. Microbiol. 28 (1990) 2394-2397
22. Jonathan N. Diagnostic utility of BINAX NOW RSV - an evaluation of the diagnostic performance of BINAX NOW RSV in comparison with cell culture and direct immunofluorescence. Ann. Clin. Microbiol. Antimicrob. 5 (2006) 13
23. Kilani R.A. Respiratory syncytial virus (RSV) outbreak in the NICU: description of eight cases. J. Trop. Pediatr. 48 (2002) 118-122
24. Kuypers J., Wright N., Ferrenberg J., Huang M.L., Cent A., Corey L., and Morrow R. Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children. J. Clin. Microbiol. 44 (2006) 2382-2388
25. Lanari M., Rossi G.A., Merolla R., and di Luzio Paparatti U. High risk of nosocomial-acquired RSV infection in children with congenital heart disease. J. Pediatr. 145 (2004) 140 (author reply 140-1)
26. Leclair J.M., Freeman J., Sullivan B.F., Crowley C.M., and Goldmann D.A. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N. Engl. J. Med. 317 (1987) 329-334
27. Macartney K.K., Gorelick M.H., Manning M.L., Hodinka R.L., and Bell L.M. Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control. Pediatrics 106 (2000) 520-526
28. McIntosh E.D., De Silva L.M., and Oates R.K. Clinical severity of respiratory syncytial virus group A and B infection in Sydney, Australia. Pediatr. Infect. Dis. J. 12 (1993) 815-819
29. McIntosh K. Community-acquired pneumonia in children. N. Engl. J. Med. 346 (2002) 429-437
30. Meissner H.C. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr. Infect. Dis. J. 22 (2003) S40-S44 (discussion S44-5)
31. Meissner H.C., and Long S.S. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 112 (2003) 1447-1452
32. Ogra P.L. Respiratory syncytial virus: the virus, the disease and the immune response. Paediatr. Respir. Rev. 5 Suppl A (2004) S119-S126
33. Panitch H.B. Viral respiratory infections in children with technology dependence and neuromuscular disorders. Pediatr. Infect. Dis. J. 23 (2004) S222-S227
34. Puppe W., Weigl J.A., Aron G., Grondahl B., Schmitt H.J., Niesters H.G., and Groen J. Evaluation of a multiplex reverse transcriptase PCR ELISA for the detection of nine respiratory tract pathogens. J. Clin. Virol. 30 (2004) 165-174
35. Ribes J.A., Seabolt J.P., and Overman S.B. Performance characteristics of VIDAS and directigen respiratory syncytial virus (RSV) antigen detection assays and culture for the identification of RSV in respiratory specimens. J. Clin. Microbiol. 40 (2002) 1818-1820
36. Rietveld E., De Jonge H.C., Polder J.J., Vergouwe Y., Veeze H.J., Moll H.A., and Steyerberg E.W. Anticipated costs of hospitalization for respiratory syncytial virus infection in young children at risk. Pediatr. Infect. Dis. J. 23 (2004) 523-529
37. Simon A., Khurana K., Wilkesmann A., Muller A., Engelhart S., Exner M., Schildgen O., Eis-Hubinger A.M., Groothuis J.R., and Bode U. Nosocomial respiratory syncytial virus infection: impact of prospective surveillance and targeted infection control. Int. J. Hyg. Environ. Health 209 (2006) 317-324
38. Swierkosz E.M., Flanders R., Melvin L., Miller J.D., and Kline M.W. Evaluation of the Abbott TESTPACK RSV enzyme immunoassay for detection of respiratory syncytial virus in nasopharyngeal swab specimens. J. Clin. Microbiol. 27 (1989) 1151-1154
39. Terletskaia-Ladwig E., Enders G., Schalasta G., and Enders M. Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study. BMC Infect. Dis. 5 (2005) 20
40. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics 102 (1998) 531-537
41. Thorburn K., Kerr S., Taylor N., and van Saene H.K. RSV outbreak in a paediatric intensive care unit. J. Hosp. Infect. 57 (2004) 194-201
42. Thwaites R., and Piercy J. Nosocomial respiratory syncytial virus infection in neonatal units in the United Kingdom. Acta Paediatr. Suppl. 93 (2004) 23-25
43. Wilkesmann A., Schildgen O., Eis-Hubinger A.M., Geikowski T., Glatzel T., Lentze M.J., Bode U., and Simon A. Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections. Eur. J. Pediatr. 165 (2006) 467-475